Development and Evaluation of a Novel Inhalable Liposomal Powder Co-Encapsulating ASSNAC and Pirfenidone via Spray Freeze-Drying for Targeted Pulmonary Fibrosis Therapy
Qinxiu Zhang, Shouwei Sun, Miaomiao Lu, Runxin Qin, Junxuan Ren, Lianjie Yao, Dianlong Jia, Jinjie Chang, Xiaohong Chu, Rui Wang, Fang Liu, Jun Li · 2026
Read Development and Evaluation of a Novel Inhalable Liposomal Powder Co-Encapsulating ASSNAC and Pirfenidone via Spray Freeze-Drying for Targeted Pulmonary Fibrosis Therapy by Qinxiu Zhang, Shouwei Sun, Miaomiao Lu, Runxin Qin, Junxuan Ren, Lianjie Yao, Dianlong Jia, Jinjie Chang, Xiaohong Chu, Rui Wang, Fang Liu, Jun Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610831.txt.
Description
Qinxiu Zhang and eleven co-authors build an inhalable powder that carries two drugs together into scarred lungs, in this 2026 study. The target is pulmonary fibrosis, a lung scarring with few treatments. One drug, pirfenidone, works but reaches the lungs poorly when swallowed and burdens liver and stomach; the second, ASSNAC, fights inflammation and oxidation.
The team packed both drugs into liposomes and turned them into a dry powder by spray freeze-drying, using L-leucine to give particles a rough, water-shy surface. Over sixty percent of the powder reached the fine-particle range suited to deep lungs. In cell studies the particles entered lung and fibroblast cells without toxicity and calmed a lab fibrosis model. In rats with induced lung scarring, the inhaled powder eased tissue injury and collagen buildup and restored the lungs' chemical balance. The authors propose it as a safer route than swallowing pirfenidone.
Catalog record
| CREATOR | Qinxiu Zhang, Shouwei Sun, Miaomiao Lu, Runxin Qin, Junxuan Ren, Lianjie Yao, Dianlong Jia, Jinjie Chang, Xiaohong Chu, Rui Wang, Fang Liu, Jun Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |